Riociguat is a soluble guanylate cyclase (sGC) agonist, mainly indicated for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). It effectively dilates pulmonary blood vessels and reduces pulmonary arterial pressure by potentiating the NO-sGC-cGMP signaling pathway.
Contact Us Product Name: Riociguat
Molecular Formula: C20H19FN8O2
Molecular Weight: 422.42
Assay: ≥99%
Appearance: Off-white to pale yellow solid
CAS：625115-55-1
Structural Formula:
Product Description:
Riociguat is a soluble guanylate cyclase (sGC) agonist, mainly indicated for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). It effectively dilates pulmonary blood vessels and reduces pulmonary arterial pressure by potentiating the NO-sGC-cGMP signaling pathway.
